Abstract Cells of B-cell Chronic Lymphocytic Leukemia (B-CLL) are characterized by short telomeres despite a low proliferative index. Since telomere length has been reported to be a valuable prognosis criteria, there is a great interest in a deep understanding of the origin and consequences of telomere dysfunction in this pathology. Cases of chromosome fusion involving extremely short telomeres have been reported at advanced stage. In the present study, we address the question of the existence of early telomere dysfunction during B-CLL time course. In a series restricted to 23 newly diagnosed Binet stage A CLL patients compared to 12 healthy donors, we found a significant increase in recruitment of DNA damage factors to telomeres showing telomere dysfunction in early stage of the disease.
Introduction
Telomeres erosion in proliferating cells leads to senescence 2 and is thereby a potent barrier for tumor progression 3 . In normal proliferating cells, such as germ and stem cells and in cancer cells, this erosion is compensated mainly by a specialized reverse transcriptase named telomerase 45 . This enzyme is crucial in cancer cells for tumour progression 6 . However, telomere shortening due to telomerase invalidation can also cooperate with p53 deficiency to facilitate carcinogenesis in aged mice 7 . In Chronic Lymphocytic Leukemia (CLL), despite a low proliferative index, telomeres are abnormally shortened 8 and we previously reported a low telomerase expression level 1 . In this context, both the consequence and the origins of telomere shortening are still a matter of debate 9 . This point is of great importance as telomere shortening has been shown to be an even better prognosis marker than the reference one, namely the mutational status of IGHV gene 10 . In this way, recent publications reported the presence of deprotected telomeres in radio-resistant patient cells 11 and fused telomeres bearing extremely short telomeres in patients mainly at advances stages of the disease 12 . Both of these papers proposed that telomere dysfunction or crisis can be at the origin of genomic instability and karyotype abnormality accumulation observed during disease progression.
A priori, the telomere injuries observed in CLL could stem from an excessive telomere shortening or alteration in the protective chromatin structure that cap telomeres or both.
Indeed, if maintenance of telomere length depends on telomerase 13 , telomere protection involves various telomere-associated proteins, such as the shelterin complex 2 composed of six proteins (TRF1, TRF2, RAP1, TIN2, TPP1, POT1) 14 ( Figure 1 ). This complex appears to act as a hub that protects telomeres from being recognized as a double strand break, thereby avoiding inappropriate DNA Damage Response (DDR) activation and aberrant repair 15 ( Figure 1 ). This complex also controls telomere length, by regulating both the telomerase activity [16] [17] [18] [19] and the Alernative Lengthening of telomere (ALT) mechanism 20 . These proteins
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From are also involved in oncogenesis. For instance, TRF2 is up-regulated in various types of human tumors 21 and has been found to display oncogenic properties in mouse keratinocytes 22 and human cancer cell lines 23 . Human telomeres are also composed of nucleosomes that exhibit repressive chromatin marks, such as H3K9 and H4K20 trimethylation and low histone acetylation level 24 associated to a hypermethylation of CpG in the subtelomeric regions. In agreement with a role for these chromatin modifications in telomere length control, the invalidation of enzymes responsible for their formation, i.e. histone methyltransferase such as Suv39h1, Suv39h2, Suv4-20h or DNA methyl transferase as DMNT1, 3a and 3b, leads to changes in telomere size [25] [26] [27] .
We have previously showed a global deregulation of the expression of shelterin proteins in an heterogeneous cohort of CLL patients 1 .
Here, we address the question of whether telomere dysfunction occurs at early stages of CLL and, if yes, whether it can be correlated with telomere shortening and/or changes in the telomere chromatin cap. As an early sign of telomere dysfunction, we monitored the recruitment at telomeres of DNA damage response proteins. Thus, we restricted our analysis to B cells from 23 patients of first stage of CLL leukemogenesis (Binet stage A, less than two years of disease history, previously un-treated).
We used B cells from 12 healthy age-matched donors as control.
We found a significant increase in telomeric damage in CLL patients in comparison with healthy donors. Strikingly, the presence of dysfunctional telomere at this early stage of the disease did not correlate with short telomeres but rather with a down-regulation of two shelterin genes: ACD and TINF2. We thus propose that early telomere deprotection in CLL results from shelterin dysregulation rather than from telomere shortening. 29 30 .
Isolation of human B cells
B lymphocytes were purified from peripheral blood by using the human CD19 Microbeads kit 
Statistical analyses
Considering the sample size, we performed nonparametric two-sample Wilcoxon Rank-Sum tests (also called Mann-Whitney U test), using R software to test significance of mean differences in each experiment.
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Results

Study design
We performed our experiments on B lymphocytes purified from the peripheral blood of 12 healthy donors and 23 newly diagnosed and previously un-treated stage A CLL patients coming from two different hospitals. The patients fulfilled the classical CLL phenotypic and molecular criteria (Table 1 and see material and method). As expected 31, 32 , the CLL patients exhibited an increased BCL2 expression and decreased Ki67 expression, known to be responsible for a higher anti-apoptotic activity in a low proliferating rate context (Figure 2A ). These data confirm a previous study showing the presence of TIF in CLL cells 11 and further
show that TIF occur during early stage of CLL. It is worth noting that the increase of TIF in CLL might have been underestimated since very short telomeres might not lead to detectable TRF1-positive foci.
Telomere deprotection in CLL patients does not correlate with mean telomere length
Since CLL cells have shorter telomeres than normal B cells, we asked whether the increased frequency of TIF in CLL patients is due to an excessive telomere shortening. Strikingly, whereas telomeres tend to be shorter in the TIF+ healthy subgroup, this is not the case in the TIF+ CLL subgroup (Figure 4 ). We also used as a cutoff the maximal number of TIF observed in healthy donors, this segregated CLL patients into two equal groups (TIF low and TIF high). Even using this method we failed to observed a diminution in telomere size in the TIF high subgroup (Supplemental Figure 1) . Thus, if a shorter telomere length could be the principal cause of telomere dysfunction in normal B cells, it does not seem to be the case in CLL cells of stage A patients. This suggests that the appearance of TIF in early stages of the disease does not mainly result from replicative erosion but rather from altered capping functions. This does not exclude the possibility that some TIFs result from a complete or nearly complete deletion of telomeres as previously observed in more advanced stage 12 . In agreement with this view, whereas no clear correlation is found between telomere shortening and TIF increase when normal individuals are compared to stage A patients (p=0.1526), the correlation is significant (p= 0.0047) when comparing normal individuals to 4 cases of stage B and C patients (Supplemental Figure 1) .
Telomeric nucleosome status in CLL
Next, we wonder if telomeric chromatin alterations could explain TIF formation in CLL cells.
Thus, we performed chromatin immunoprecipitation (ChIP) experiments against histone modifications known to characterize "repressive"(H3 lysine 9 trimethylation: H3K9trim), or "active" chromatin (H3 lysine 9 acetylation: H3K9ac) and against total histone H3. We used an irrelevant IgG (IgG) as a control and estimated telomeric versus Alu sequences enrichment in the immunoprecipitated fractions. We did not observe any significant alterations of the tested histone marks in CLL as compared to normal samples, although we noted a trend toward an increased H3K9ac in CLL samples (p = 0.0539) ( Figure 5A-B) . Interestingly, we also observed a propensity of the TIF+ healthy subgroup toward an increased presence of the H3K9ac mark at telomeres while this trend is totally lost in the TIF+ subgroups of CLL patients ( Figure 5C 
Discussion
We report here for the first time a telomere dysfunction in early stages of CLL. Interestingly, the presence of Telomere DNA damage Induced Foci (TIF) in CLL patients correlates with a reduced expression of the ACD and TINF2 shelterin genes but not with short telomeres.
It was previously reported that telomere shortening due to cell proliferation (in the absence of telomerase) results in TIF accumulation associated with an increase in telomeric H3K9 acetylation 37, 38 . In agreement with this scheme, we found that the presence of TIF in normal B cells tends to correlate with shorter telomeres and an increased presence of H3K9ac at telomere. However, there is no tendency toward telomere shortening in patients harboring a detectable level of TIF. Thus, the TIF increase in our cohort of stage A patients cannot be merely explained by telomere shortening due to cell over-proliferation. In agreement with previous works showing an increased rate of proliferation 39 and telomere crisis 12 in advanced stage of CLL, we observed a significant correlation between the presence of TIF and short telomeres in patients at stages B and C. We therefore conclude that early stages of CLL is associated with telomere deprotection, which can not be merely explained by telomere shortening, while advanced stages, probably as a consequence of an increased number of cell divisions, lead to critically short telomeres triggering DNA damage response and chromosome end fusion.
We noted a global decrease in the expression of shelterin component encoding genes in the stage A CLL patients harbouring telomere damage and in particular a significant decrease in the expression of both ACD and TINF2 genes. Considering the shelterin complex conformation, TRF1 and TRF2 bind the duplex telomeric DNA and POT1 the single strand 3'
overhang. POT1 function as an heterodimer with TPP1 (encoded by ACD) which enhances its binding to telomeres 12 . TIN2 (encoded by TINF2) plays a major role in the complex stabilization, by bridging TPP1, TRF1 and TRF2 40, 41 . Thus, both ACD and TINF2 encode
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proteins playing a central role in the formation of the shelterin protein bridge linking the duplex part to the 3' overhang of telomeric DNA. Their loss is thus expected to dissociate an essential capping structure [40] [41] [42] [43] . Therefore, we propose that increased TIF occurrence in stage A CLL patients results, at least in part, from a partial disassembly of the shelterin complex.
What could be the role of damaged telomeres in CLL pathogenesis? Since the presence of TIF is a hallmark of senescent cells 36 and of senescent T lymphocytes in particular 44 , we propose that early stage CLL is associated to accelerated B lymphocyte senescence. This might result from the accumulation of various telomere dysfunctions in the B cell lineage, including telomerase and shelterin down regulation ( 1 and this work). In agreement with this view, CLL B cells are known to be initially G0 arrested 45 and we observed an increase in p16 expression in our cohort of CLL patients (Figure 2A ). Escape from senescence induce telomere excessive shortening, fusion and cell crisis entry and promote genome instability 7 . Increase in cell To our knowledge, this work provides the first evidence of telomere deprotection in a human malignancy in link with an alteration of the shelterin complex. Interestingly, these damages occur at an early stage of the disease, suggesting that they contribute to the early step of malignant transformation. This enlightens the concept, well documented in mouse models but still hypothetical in human cancer, that telomere dysfunction facilitates cancer initiation 7, 46 . N120  NA  NA  NA  NA  NA  NA  NA  ND  N121  NA  NA  NA  NA  NA  NA  NA  N122  NA  NA  NA  NA  NA  NA  NA  ND  N123  NA  NA  NA  NA  NA  NA  NA  ND  N124  NA  NA  NA  NA  NA  NA  NA  N125  NA  NA  NA  NA  NA  NA  NA  N126  NA  NA  NA  NA  NA  NA  NA  N127  NA  NA  NA  NA  NA  NA  NA  ND  ND  N128  NA  NA  NA  NA  NA  NA  NA  N129  NA  NA  NA  NA  NA  NA  NA  ND  N132  NA  NA  NA  NA  NA  NA  NA  N133  NA  NA  NA  NA  NA  NA  NA 
